Trial Profile
FATA: Comparison Between Tirofiban and Abciximab in Facilitated Angioplasty With Stent Implantation: Randomized Multicentre Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary) ; Abciximab
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- Acronyms FATA
- 15 Jan 2008 Status changed from recruiting to completed.
- 22 Oct 2006 New trial record.